ArticleGenome biology and evolution2025
The Evolution of Function in the DNA-Binding Domain of the CRP/FNR Family.
Article in Genome biology and evolution, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Early Evolution of the Prokaryotic Transcription Factor Repertoire.Genome biology and evolution · 2026Article
- A Structure-Based Analysis of the Evolution of Transcription Factors of the FNR/CRP Family.Biomolecules · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Transcriptional regulation, facilitated by transcription factors (TFs), contributes to bacterial response to environmental and cellular perturbations. How have TFs diversified and gained their functions? We use the cyclic AMP receptor protein (CRP)/regulator of fumarate and nitrate reductase (FNR) family to study this question across ∼6,000 prokaryotic genomes. Characterized by homology to TFs CRP and FNR in Escherichia coli, the two functions of this family-sequence-specific DNA binding and transcriptional activation by direct contacts to RNA polymerase-are conferred by the helix-turn-helix containing DNA-binding domain. We constructed a rooted phylogeny of this domain and performed residue conservation analysis on extant and in silico reconstructed ancestral sequences of CRP/FNR family members. The overall ancestor of the sequence family does not fall into classes containing either E. coli CRP (Eco-CRP) or E. coli FNR (Eco-FNR) clades, but instead a large and diverse class that we call "CRP-like." Residues key for base-specific DNA binding remain largely conserved in the family, and likely emerged in the family common ancestor. Residues (together called activating region 1 site [AR1]) that make direct contacts with α-C-terminal domain (αCTD) of RNA polymerase are conserved only in the Eco-CRP class and restricted to Gammaproteobacteria. The corresponding "287 determinant" interface on αCTD is again fully conserved only in Gammaproteobacteria, which contain Eco-CRP members, following stepwise evolution initiated at the Proteobacterial common ancestor. These suggest suggesting co-emergence of the interface residues in Eco-CRP. Our analysis hence shows that class I transcriptional activation through AR1 on CRP and the determinant of αCTD, as described in E. coli CRP, is phylogenetically restricted, while base-specific DNA binding has been present in the CRP/FNR family throughout its evolutionary history.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.